Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: just another hypothesis billwilke;gohorns

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jldmt

Rank: Treasurer [?]

Points: 6320 [?]

Votes: 85 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: just another hypothesis billwilke;gohorns - Valuation

in response to

Re: just another hypothesis billwilke

gohorns

posted on May 06, 2008 08:00AM

This statement is on PTSC's web site.

Joint Venture Partners

Patriot Scientific Corporation (OTC Bulletin Board: PTSC) and The TPL Group are equal owners in a joint venture that unified their interests in a series of fundamental microprocessor patents that are at the heart of a global $200 billion-plus microprocessor end-use market. more >>

I was under the impression this 200 billion market was being used to estimate our patents worth. I've have read here that with a 1% royalty/license value our patents were worth 2 billion not 1 billion. Your estimate of .80 per share value based on our half(gross) should actually be doubled IMO to approx. $1.60. Recently there have been statements made that the end user market for microprocessors has actually grown to between 300-400 billion. Thus, implying an even greater value of our patents.